(CIM) Chimera Investment - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US16934Q2084

CIM: Mortgage Loans, Mortgage-Backed Securities, Real Estate Securities

Chimera Investment Corporation (NYSE:CIM) is a U.S.-based real estate investment trust (REIT) that specializes in mortgage-backed assets, operating at the intersection of real estate and fixed-income markets. Established in 2007 and headquartered in New York, the company has carved out a niche as a mortgage REIT, focusing on a diverse portfolio of mortgage-related securities and loans. Its strategy involves investing in both agency and non-agency residential mortgage-backed securities (RMBS), as well as commercial mortgage-backed securities (CMBS). Additionally, it holds business purpose and investor loans, which are increasingly important in today’s real estate market.

Chimera’s portfolio spans investment-grade, non-investment-grade, and non-rated securities, reflecting its willingness to take calculated risks in pursuit of higher yields. This approach allows the company to capitalize on opportunities across different segments of the mortgage market, from government-backed loans to more complex, private mortgage-backed securities. As a REIT, Chimera is required to distribute at least 90% of its taxable income to shareholders, making it an attractive option for income-focused investors.

With a market capitalization of approximately $1.14 billion, Chimera operates at a scale that allows it to navigate the complexities of the mortgage markets while maintaining a diversified portfolio. Its financial metrics, including a price-to-book (P/B) ratio of 0.45 and a trailing P/E of 12.90, suggest that the market is pricing in both the potential for future growth and the inherent risks of its asset classes. The forward P/E of 7.67 indicates expectations of improving earnings, while the price-to-sales (P/S) ratio of 4.13 reflects the company’s ability to generate revenue from its mortgage investments.

For investors and fund managers, Chimera offers exposure to the U.S. housing market and the broader mortgage finance ecosystem. Its focus on both agency and non-agency securities provides a balance between stability and potential upside, though it also introduces risks tied to interest rate fluctuations, credit performance, and regulatory changes. As with any mortgage REIT, understanding the interplay between interest rates, housing market dynamics, and the company’s leverage is critical for evaluating its long-term prospects.

Additional Sources for CIM Stock

CIM Stock Overview

Market Cap in USD 944m
Sector Real Estate
Industry REIT - Mortgage
GiC Sub-Industry Mortgage REITs
IPO / Inception 2007-11-16

CIM Stock Ratings

Growth Rating -19.4
Fundamental 27.7
Dividend Rating 35.9
Rel. Strength -9.53
Analysts 3/5
Fair Price Momentum 12.50 USD
Fair Price DCF 55.86 USD

CIM Dividends

Dividend Yield 12m 11.23%
Yield on Cost 5y 11.38%
Annual Growth 5y -19.50%
Payout Consistency 78.8%

CIM Growth Ratios

Growth Correlation 3m -92.6%
Growth Correlation 12m 12%
Growth Correlation 5y -66.7%
CAGR 5y -0.78%
CAGR/Max DD 5y -0.01
Sharpe Ratio 12m 0.10
Alpha 2.11
Beta 0.612
Volatility 46.47%
Current Volume 634.6k
Average Volume 20d 630.3k
What is the price of CIM stocks?
As of May 01, 2025, the stock is trading at USD 12.34 with a total of 634,557 shares traded.
Over the past week, the price has changed by +6.56%, over one month by -3.82%, over three months by -14.72% and over the past year by +11.01%.
Is Chimera Investment a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Chimera Investment is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 27.71 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CIM as of May 2025 is 12.50. This means that CIM is currently overvalued and has a potential downside of 1.3%.
Is CIM a buy, sell or hold?
Chimera Investment has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold CIM.
  • Strong Buy: 0
  • Buy: 0
  • Hold: 5
  • Sell: 0
  • Strong Sell: 0
What are the forecast for CIM stock price target?
According to ValueRays Forecast Model, CIM Chimera Investment will be worth about 13.5 in May 2026. The stock is currently trading at 12.34. This means that the stock has a potential upside of +9.4%.
Issuer Forecast Upside
Wallstreet Target Price 14 13.5%
Analysts Target Price 15.8 27.6%
ValueRay Target Price 13.5 9.4%